| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/29/2013 | US8361994 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/29/2013 | US8361972 Pharmaceutical formulations containing an SGLT2 inhibitor |
| 01/29/2013 | US8361968 Metastin derivatives and use thereof |
| 01/29/2013 | US8361751 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost |
| 01/29/2013 | US8361466 Tweak receptor |
| 01/29/2013 | US8361443 Peptide-based compounds |
| 01/29/2013 | CA2694835C Novel crystalline form |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2525946C Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 01/29/2013 | CA2522645C New monoclonal antibody capable of binding integrin alpha10beta1 |
| 01/29/2013 | CA2431891C Mutations in neuronal gene sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 01/24/2013 | WO2013012945A1 Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012049A1 Heart failure preventing agent |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010839A1 Novel and selective ccr2 antagonists |
| 01/24/2013 | WO2013010573A1 Compounds with matrix-metalloproteinase inhibitory activity |
| 01/24/2013 | WO2013010380A1 Btk inhibitors |
| 01/24/2013 | WO2013010241A1 Pharmaceutical composition for the treatment of arterial hypertension, based on the co-administration of anti-hypertensive agents and angiotensin (1-7) or another mas receptor agonist |
| 01/24/2013 | WO2012163088A3 Medicine for treating kidney and heart disease and the uses thereof |
| 01/24/2013 | US20130023714 Medical and Imaging Nanoclusters |
| 01/24/2013 | US20130023584 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023583 Theaflavin Compositions, Related Processes and Methods of Use |
| 01/24/2013 | US20130023579 Modulation of angiopoietin-like 3 expression |
| 01/24/2013 | US20130023575 Compositions and methods for the treatment of ocular surface allergies |
| 01/24/2013 | US20130023572 Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating skin diseases |
| 01/24/2013 | US20130023569 Use of Deferiprone for Treatment and Prevention of Iron-Related Eye Disorders |
| 01/24/2013 | US20130023564 Piperidinyl derivative as a modulator of chemokine receptor activity |
| 01/24/2013 | US20130023558 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[4,5-c]PYRIDINE RING |
| 01/24/2013 | US20130023557 Carboxylic acid derivatives having an oxazolo[5,4-b]pyridine ring |
| 01/24/2013 | US20130023556 Autotaxin inhibitors |
| 01/24/2013 | US20130023547 Dispersible tablet |
| 01/24/2013 | US20130023545 Cycloalkyloxycarboxylic acid derivatives |
| 01/24/2013 | US20130023544 CARBOXYLIC ACID DERIVATIVES HAVING AN OXAZOLO[5,4-d]PYRIMIDINE RING |
| 01/24/2013 | US20130023542 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/24/2013 | US20130023537 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023526 Isoxazolines as Therapeutic Agents |
| 01/24/2013 | US20130023524 Tricyclic indazole compound, method of preparation and pharmaceutical composition containing it |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023520 Anaesthetic eye solution and method of use |
| 01/24/2013 | US20130023517 Therapeutic methods employing substituted piperidines which are CCR3 antagonists |
| 01/24/2013 | US20130023514 Substituted pyrrolotriazines as protein kinase inhibitors |
| 01/24/2013 | US20130023513 Methods and Compositions for Treating Cardiovascular Disorders |
| 01/24/2013 | US20130023509 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023508 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023507 Hyaluronic acid based copolymers |
| 01/24/2013 | US20130023504 Modulation of Prostaglandin/Cyclooxygenase Metabolic Pathways |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023498 MicroRNA Modulators and Method for Identifying and Using the Same |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023489 Compositions and methods for preventing and treating diseases and environmentally induced health disorders |
| 01/24/2013 | US20130023488 Methods and compounds for reducing intracellular lipid storage |
| 01/24/2013 | US20130023483 Template-fixed peptidomimetics with cxcr7 modulating activity |
| 01/24/2013 | US20130023473 Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
| 01/24/2013 | US20130023470 Exendin and exendin agonists for eating disorders |
| 01/24/2013 | US20130023466 Peptide YY and Peptide YY Agonists for Treatment of Metabolic Disorders |
| 01/24/2013 | US20130022679 Controlled Release and Taste Masking Oral Pharmaceutical Composition |
| 01/24/2013 | US20130022677 Delayed prolonged drug delivery |
| 01/24/2013 | US20130022675 Drug delivery system |
| 01/24/2013 | US20130022671 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/24/2013 | US20130022666 Methods and compositions for transfer of mitochondria into mammalian cells |
| 01/24/2013 | US20130022663 Method of making and using a topical medicated formula and delivery system to use to prevent and treat breast diseases and breast cancer as well as use as skin wellness and anti-wrinkle formula |
| 01/24/2013 | US20130022660 Drug delivery system for the prevention of cerebral vasospasm |
| 01/24/2013 | US20130022644 Novel n-phenylacetamide derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them |
| 01/24/2013 | US20130022630 Method for treating amyloid disease |
| 01/24/2013 | US20130022617 Compositions and methods for treating tumors, fibrosis, and pulmonary alveolar proteinosis |
| 01/24/2013 | US20130022599 Method of treating fibroproliferative disorders |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022584 Methods and compositions for the repair and/or regeneration of damaged myocardium using cytokines and variants thereof |
| 01/24/2013 | US20130022551 DEspR ANTAGONISTS AND AGONISTS AS THERAPEUTICS |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2842072A1 Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy |
| 01/24/2013 | CA2841899A1 Btk inhibitors |
| 01/24/2013 | CA2841724A1 Heart failure suppressing agent |
| 01/23/2013 | EP2548880A2 Compositions for increasing telomerase activity |
| 01/23/2013 | EP2548879A1 Crystal of diamine derivative and method of producing same |
| 01/23/2013 | EP2548874A2 Substituted piperazines as CB1 antagonists |
| 01/23/2013 | EP2548872A1 Cyclopropanecarboxylic acid derivative |
| 01/23/2013 | EP2548871A1 Cycloalkyl-substituted imidazole derivative |
| 01/23/2013 | EP2548569A1 Stem cell derived factors for treating pathologic conditions |
| 01/23/2013 | EP2548453A1 High-potency sweetener for hydration and sweetened hydration composition |
| 01/23/2013 | EP2547352A1 Combination therapies using cyclosporine and aromatic cationic peptides |
| 01/23/2013 | EP2547341A1 Treatment for pulmonary hypertension |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892882A Reducing agent from microorganism belonging to genus bacillus and application for same |
| 01/23/2013 | CN102892425A Treatment of cardiac conditions |
| 01/23/2013 | CN102892423A Adiponectin production accelerating composition |
| 01/23/2013 | CN102888403A Application of micro ribonucleic acid (miRNA)-539 and miRNA-539antisense nucleotide, and medicinal composition for miRNA-539 antisense nucleotide |
| 01/23/2013 | CN102888401A Inhibitor for inducing pluripotent stem cells, and inducing method and application thereof |
| 01/23/2013 | CN102888279A Extracting method of corn stigma essential oil |
| 01/23/2013 | CN102887941A PAK (polyester alkyd)/ imidazoline/RGD (arginine-glycine-aspartic acid) ternary conjugate and preparation method and use thereof |
| 01/23/2013 | CN102887861A New crystal form of Ambrisentan and preparation method thereof |
| 01/23/2013 | CN102886051A Application of Klotho adeno-associated virus to preparation of medicine for treating hypertensive heart disease of spontaneous hypertensive rat (SHR) |
| 01/23/2013 | CN102886050A Application of miRNA-489 and medicinal composition |
| 01/23/2013 | CN102886015A Preparation for restoring consciousness and calming nasal mucosa and preparation method thereof |
| 01/23/2013 | CN102885987A Oral liquid for quickly treating essential hypertension |
| 01/23/2013 | CN102885985A Preparation method and application of rhizoma gastrodiae and rhizoma chuanxiong compound extract |
| 01/23/2013 | CN102885984A Pharmaceutical composition for treating hypertension |
| 01/23/2013 | CN102885983A Chinese medicinal composition for treating stroke |